Taking Quinazoline as a General Support-Nog to Design Potent and Selective Kinase Inhibitors: Application to FMS-like Tyrosine Kinase 3

摘要：

The dramatic success of the first approved protein kinase inhibitor imatinib (Gleevec) for the treatment of chronic myelog-enous leukemia has fueled an explosion in kinase inhibitor research in both the

作者: Wei-Wei Li Luo-Ding Yu Li-Juan Chen Yu-Quan Wei Sheng-Yong Yang Jin-Juan Chen Ren-Lin Zheng Wen-Qin Zhang Zhi-Xing Cao Ling-Ling Yang Xiao-Yu Qing Liang-Xue Zhou Li Yang

作者单位: State Key Laboratory of Biotherapy, West China Hospital West China Medical School, Sichuan Universit State Key Laboratory of Biotherapy, West China Hospital West China Medical School, Sichuan Universit

会议类型: 国际会议

会议名称: The 5th International Conference of Molecular Simulations and Applied Informatics Technologies(第五届国际分子模拟与信息技术应用学术会议 ICMS&I)

会议地点: 武汉

会议语种:英文

页码: 67-70

在线出版日期: 2010-09-01（万方平台首次上网日期，不代表论文的发表时间）